CheckMate 214 post-hoc analyses of nivolumab plus ipilimumab or sunitinib in IMDC intermediate/poor-risk patients with previously untreated advanced renal cell carcinoma with sarcomatoid features Meeting Abstract
| Authors: | McDermott, D. F.; Choueiri, T. K.; Motzer, R. J.; Aren, O. R.; George, S.; Powles, T.; Donskov, F.; Harrison, M. R.; Cid, J. R. R. R.; Ishii, Y.; McHenry, M. B.; Mekan, S. F.; Rini, B. I.; Tannir, N. M. |
| Abstract Title: | CheckMate 214 post-hoc analyses of nivolumab plus ipilimumab or sunitinib in IMDC intermediate/poor-risk patients with previously untreated advanced renal cell carcinoma with sarcomatoid features |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 267s |
| Language: | English |
| ACCESSION: | WOS:000487345805339 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.4513 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4513 -- Source: Wos |
